E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 870 KRW -2.14% Market Closed
Market Cap: 433.7B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
EuBiologics Co Ltd

Wall Street analysts forecast EuBiologics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EuBiologics Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

Lowest
Price Target
16 160 KRW
36% Upside
Average
Price Target
16 320 KRW
37% Upside
Highest
Price Target
16 800 KRW
42% Upside
EuBiologics Co Ltd Competitors:
Price Targets
PYXS
Pyxis Oncology Inc
495% Upside
ARGX
argenx SE
2% Downside
IMTX
Immatics NV
146% Upside
EXAS
Exact Sciences Corp
24% Upside
ABBV
Abbvie Inc
20% Upside
AMGN
Amgen Inc
28% Upside
HPHA
Heidelberg Pharma AG
408% Upside
QNCX
Quince Therapeutics Inc
416% Upside

Revenue
Forecast

Revenue Estimate
EuBiologics Co Ltd

For the last 8 years the compound annual growth rate for EuBiologics Co Ltd's revenue is 60%. The projected CAGR for the next 3 years is 25%.

60%
Past Growth
25%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
EuBiologics Co Ltd

The compound annual growth rate of EuBiologics Co Ltd's operating income for the next 3 years is 70%.

N/A
Past Growth
70%
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

Net Income Estimate
EuBiologics Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EuBiologics Co Ltd's stock price target?
Price Target
16 320 KRW

According to Wall Street analysts, the average 1-year price target for EuBiologics Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

What is EuBiologics Co Ltd's Revenue forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for EuBiologics Co Ltd's revenue is 60%. The projected CAGR for the next 3 years is 25%.

What is EuBiologics Co Ltd's Operating Income forecast?
Projected CAGR
70%

The compound annual growth rate of EuBiologics Co Ltd's operating income for the next 3 years is 70%.

Back to Top